• Vertex Pharmaceuticals 2024 EBITDA was -0.026B, a 100.64% decline from 2023.
• Vertex Pharmaceuticals 2023 EBITDA was 4.013B, a 9.93% decline from 2022.
• Vertex Pharmaceuticals 2022 EBITDA was 4.456B, a 53.24% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.